Absorption Models to Examine Bioavailability and Drug–Drug Interactions in Humans-Reference-Cited by-同舟云学术

Absorption Models to Examine Bioavailability and Drug–Drug Interactions in Humans

Published:2009-10-24 Issue: Volume: Page:343-370
ISSN:
Container-title:Enzyme- and Transporter-Based Drug-Drug Interactions
language:
Short-container-title:

Author:

Rizwan Ahsan Naqi,Brouwer Kim L.R.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0840-7_14.pdf

Reference57 articles.

1. Bergman E, Forsell P, Persson EM, Knutson L, Dickinson P, Smith R, Swaisland H, Farmer MR, Cantarini MV and Lennernäs H (2007) Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors. Int J Pharm 341:134–142.

2. Bergman E, Forsell P, Tevell A, Persson EM, Hedeland M, Bondesson U, Knutson L and Lennernäs H (2006) Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. Eur J Pharm Sci 29:205–214.

3. Bode H, Brendel E, Ahr G, Fuhr U, Harder S and Staib AH (1996) Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine. Eur J Clin Pharmacol 50:195–201.

4. Clear NJ, Milton A, Humphrey M, Henry BT, Wulff M, Nichols DJ, Anziano RJ and Wilding I (2001) Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon. Eur J Pharm Sci 13:375–384.

5. ClinicalTrials.gov. NCT00744250-Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control ( http://clinicaltrials.gov/ct2/show/NCT00744250?term=pancrecarb&rank=3 ). Accessed on April 27, 2009.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRUG TRANSPORT IN THE LIVER;Drug Transporters;2022-04-05